Science Explorer Back to mapMap
Discussion
Topic · Radiology, Nuclear Medicine and Imaging

Cardiovascular Conditions and Treatments

Cardiovascular Conditions and Treatments is a research topic within Radiology, Nuclear Medicine and Imaging. Science Explorer counts 9.6k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnosis and treatment of patent ductus arteriosus (PDA) in preterm infants, with a particular emphasis on the use of indomethacin prophylaxis and ibuprofen treatment. It also explores the association between PDA and neonatal morbidity, the use of echocardiography for assessment, and the impact of ductal closure on outcomes such as bronchopulmonary dysplasia. Additionally, it examines the relationship between PDA and congenital heart disease, including cardiomyopathy.

  • Patent Ductus Arteriosus
  • Preterm Infants
  • Echocardiography
  • Indomethacin Prophylaxis
  • Cardiomyopathy
  • Ibuprofen Treatment
  • Neonatal Morbidity
  • Ductal Closure
  • Congenital Heart Disease
  • Bronchopulmonary Dysplasia
Research works
9.6k
fractional, since 1950
In the world top 10%
967
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+11%
the tick is no change
Largest producer
United States
40% of the 10 largest, 2022-now
Cardiovascular Conditions and Treatments

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Cardiovascular Conditions and Treatments research?

By volume, the United States and China publish the most (483 and 115 works in 2022-now).

By volume, 2022-now

  1. 1 United States 483 works
  2. 2 China 115 works
  3. 3 Brazil 98 works
  4. 4 Japan 96 works
  5. 5 India 92 works
  6. 6 United Kingdom 91 works
  7. 7 Italy 72 works
  8. 8 Türkiye 60 works
  9. 9 South Korea 53 works
  10. 10 Germany 51 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 39.8%China: 9.5%Brazil: 8.1%Japan: 7.9%6 others listed: 34.7%40%largest
United States483 · 39.8%China115 · 9.5%Brazil98 · 8.1%Japan96 · 7.9%6 others listed421 · 34.7%

Shares of the rows listed above, not of the whole node.

Which institutions lead Cardiovascular Conditions and Treatments research?

By volume in 2022-now, Cornell University publishes the most Cardiovascular Conditions and Treatments research, followed by Harvard University and University of California, Davis.

By volume, 2022-now

  1. 1 Cornell UniversityUnited States 15 works
  2. 2 Harvard UniversityUnited States 14 works
  3. 3 University of California, DavisUnited States 13 works
  4. 4 The Ohio State UniversityUnited States 13 works
  5. 5 North Carolina State UniversityUnited States 13 works
  6. 6 Colorado State UniversityUnited States 12 works
  7. 7 Royal Veterinary CollegeUnited Kingdom 11 works
  8. 8 Ghent UniversityBelgium 11 works
  9. 9 Texas A&M UniversityUnited States 10 works
  10. 10 All India Institute of Medical SciencesIndia 10 works

Who are the leading researchers in Cardiovascular Conditions and Treatments?

The most-cited researchers publishing on Cardiovascular Conditions and Treatments include Stephan Windecker and Patrizio Lancellotti.

  1. 1 Stephan Windecker Switzerland 338k citations
  2. 2 Patrizio Lancellotti Belgium 245k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Cardiovascular Conditions and Treatments?

The most cited paper in Cardiovascular Conditions and Treatments is "Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management" (Bradley S. Marino, Paul H. Lipkin, Jane W. Newburger et al., 2012), with 1,631 citations. Next come "Promotion of Atrial Fibrillation by Heart Failure in Dogs" (1,350) and "Tie2-Cre Transgenic Mice: A New Model for Endothelial Cell-Lineage Analysis in Vivo" (1,276).

Most cited papers
#PaperReleasedCitations
1 Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management Bradley S. Marino, Paul H. Lipkin, Jane W. Newburger et al. · Circulation 31 Jul 2012 1,631
2 Promotion of Atrial Fibrillation by Heart Failure in Dogs Danshi Li, Samir Fareh, Tack Ki Leung et al. · Circulation 6 Jul 1999 1,350
3 Tie2-Cre Transgenic Mice: A New Model for Endothelial Cell-Lineage Analysis in Vivo Yaz Y. Kisanuki, Robert E. Hammer, Jun‐ichi Miyazaki et al. · Developmental Biology Open access Feb 2001 1,276
4 Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke Jean‐Louis Mas et al. · New England Journal of Medicine Open access 13 Sep 2017 1,191
5 Recommendations for Standards in Transthoracic Two-Dimensional Echocardiography in the Dog and Cat William P. Thomas, Cathy E. Gaber, Gilbert J. Jacobs et al. · Journal of Veterinary Internal Medicine Jul 1993 1,039
All 97 most cited papers, with filters and sorting

Where is Cardiovascular Conditions and Treatments research done?

The largest centres of Cardiovascular Conditions and Treatments research in 2022-now are Tokyo (Japan), London (United Kingdom), São Paulo (Brazil) and New York (United States).

Largest cities, 2022-now

  1. 1 TokyoJapan 34 works
  2. 2 LondonUnited Kingdom 29 works
  3. 3 São PauloBrazil 27 works
  4. 4 New YorkUnited States 24 works
  5. 5 BeijingChina 16 works
  6. 6 SeoulSouth Korea 16 works
  7. 7 PhiladelphiaUnited States 15 works
  8. 8 BangkokThailand 15 works
  9. 9 IstanbulTürkiye 15 works
  10. 10 BostonUnited States 14 works
See Cardiovascular Conditions and Treatments on the map

Where is the best place to study Cardiovascular Conditions and Treatments?

Among universities, judged by research, North Carolina State University, Harvard University and University of California, Davis score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 18.04%fractional works in this field (log) →share of work in the world top 10% →University of Califo…Colorado State Unive…North Carolina State…Harvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1North Carolina State UniversityUnited States 75.818.6%15.0×13 +26.1%
2Harvard UniversityUnited States 73.418.2%2.9×14 +8.0%
3University of California, DavisUnited States 71.025.4%10.6×13 -33.9%
4Colorado State UniversityUnited States 67.420.2%22.7×12 +65.3%
5Ghent UniversityBelgium 66.117.6%9.1×11 +27.0%
6University of IowaUnited States 62.325.8%10.7×8 +197.5%
7Cornell UniversityUnited States 61.98.1%7.4×15 +19.6%
8The Ohio State UniversityUnited States 58.017.1%6.8×13 +12.4%
9Royal Veterinary CollegeUnited Kingdom 57.216.0%168.9×11 -27.1%
10Utrecht UniversityNetherlands 47.213.4%9.0×10 +124.8%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Cardiovascular Conditions and Treatments, country by country

Is Cardiovascular Conditions and Treatments research growing?

Output in 2022-2025 was 11% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Cardiovascular Conditions and Treatments.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Cardiovascular Conditions and Treatments as a percentage of every work published that year, 0.0066% in 2024.

still counting0.010%0.020%Cardiovascular Conditions and Treatments0.0076% in 202519801990200020102020

Fractional works of Cardiovascular Conditions and Treatments over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Cardiovascular Conditions and Treatments10.3% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Cardiovascular Conditions and Treatments. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.